2016 循证建议:雄激素阻断疗法治疗局限性和晚期前列腺癌

2016-06-20 国外肿瘤科相关专家小组(统称) Cent European J Urol. 2016;69(2):131-8.

前列腺癌的管理仍然在不断演变,雄激素阻断疗法是一个已经确立的治疗方法选择,尤其是针对转移性疾病的患者。本文的主要目的是回顾雄激素阻断疗法的相关证据,为男性前列腺癌的治疗及其在争议领域的应用提供建议。

中文标题:

2016 循证建议:雄激素阻断疗法治疗局限性和晚期前列腺癌

英文标题:

Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer

发布日期:

2016-06-20

简要介绍:

前列腺癌的管理仍然在不断演变,雄激素阻断疗法是一个已经确立的治疗方法选择,尤其是针对转移性疾病的患者。本文的主要目的是回顾雄激素阻断疗法的相关证据,为男性前列腺癌的治疗及其在争议领域的应用提供建议。

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 循证建议:雄激素阻断疗法治疗局限性和晚期前列腺癌)] GetToolGuiderByIdResponse(projectId=1, id=f5b971c001261071, title=2016 循证建议:雄激素阻断疗法治疗局限性和晚期前列腺癌, enTitle=Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer, guiderFrom=Cent European J Urol. 2016;69(2):131-8., authorId=null, author=, summary=前列腺癌的管理仍然在不断演变,雄激素阻断疗法是一个已经确立的治疗方法选择,尤其是针对转移性疾病的患者。本文的主要目的是回顾雄激素阻断疗法的相关证据,为男性前列腺癌的治疗及其在争议领域的应用提供建议。 , cover=, journalId=null, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jun 20 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=前列腺癌的管理仍然在不断演变,雄激素阻断疗法是一个已经确立的治疗方法选择,尤其是针对转移性疾病的患者。本文的主要目的是回顾雄激素阻断疗法的相关证据,为男性前列腺癌的治疗及其在争议领域的应用提供建议。 <div><br> 拓展指南:<strong>与<font color=red>前列腺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=084bb1c0012295f1" title="2016 中国去势抵抗性前列腺癌诊治专家共识" target=_blank>2016 中国去势抵抗性前列腺癌诊治专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=044621c00121e593" title="2015 ESMO临床实践指南:前列腺癌诊断,治疗和随访" target=_blank>2015 ESMO临床实践指南:前列腺癌诊断,治疗和随访</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b71bb1c0011990fd" title="中国前列腺癌早期诊断专家共识" target=_blank>中国前列腺癌早期诊断专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=10bb61c001198938" title="前列腺癌根治术后辅助内分泌治疗热点问题和专家共识" target=_blank>前列腺癌根治术后辅助内分泌治疗热点问题和专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4e5641c00119115e" title="2016 ASCO:积极监测局限性前列腺癌管理指南" target=_blank>2016 ASCO:积极监测局限性前列腺癌管理指南</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA%E7%99%8C" target=_blank>有关前列腺癌更多指南</a></ul></div>, tagList=[TagDto(tagId=781, tagName=前列腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5074, appHits=121, showAppHits=0, pcHits=3319, showPcHits=2123, likes=132, shares=2, comments=8, approvalStatus=1, publishedTime=Thu Aug 25 15:25:31 CST 2016, publishedTimeString=2016-06-20, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Thu Aug 25 15:25:31 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 06:27:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 循证建议:雄激素阻断疗法治疗局限性和晚期前列腺癌)])
2016 循证建议:雄激素阻断疗法治疗局限性和晚期前列腺癌
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=111010, encodeId=0366111010b5, content=继续努力, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160904/IMG57CC3DB9E3F783843.jpg, createdBy=73ac1946806, createdName=dittoy, createdTime=Sun Sep 04 23:35:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105152, encodeId=ee9d1051524f, content=恩,不错,已载下,认真拜读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:14:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104640, encodeId=8b80104640af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104641, encodeId=72d0104641c2, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104642, encodeId=4fe2104642bf, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-09-04 dittoy

    继续努力

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=111010, encodeId=0366111010b5, content=继续努力, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160904/IMG57CC3DB9E3F783843.jpg, createdBy=73ac1946806, createdName=dittoy, createdTime=Sun Sep 04 23:35:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105152, encodeId=ee9d1051524f, content=恩,不错,已载下,认真拜读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:14:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104640, encodeId=8b80104640af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104641, encodeId=72d0104641c2, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104642, encodeId=4fe2104642bf, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 1e0f7307m29(暂无匿称)

    恩,不错,已载下,认真拜读

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=111010, encodeId=0366111010b5, content=继续努力, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160904/IMG57CC3DB9E3F783843.jpg, createdBy=73ac1946806, createdName=dittoy, createdTime=Sun Sep 04 23:35:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105152, encodeId=ee9d1051524f, content=恩,不错,已载下,认真拜读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:14:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104640, encodeId=8b80104640af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104641, encodeId=72d0104641c2, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104642, encodeId=4fe2104642bf, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=111010, encodeId=0366111010b5, content=继续努力, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160904/IMG57CC3DB9E3F783843.jpg, createdBy=73ac1946806, createdName=dittoy, createdTime=Sun Sep 04 23:35:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105152, encodeId=ee9d1051524f, content=恩,不错,已载下,认真拜读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:14:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104640, encodeId=8b80104640af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104641, encodeId=72d0104641c2, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104642, encodeId=4fe2104642bf, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 doctorJiangchao

    继续关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=111010, encodeId=0366111010b5, content=继续努力, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160904/IMG57CC3DB9E3F783843.jpg, createdBy=73ac1946806, createdName=dittoy, createdTime=Sun Sep 04 23:35:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=105152, encodeId=ee9d1051524f, content=恩,不错,已载下,认真拜读, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fcad1943078, createdName=1e0f7307m29(暂无匿称), createdTime=Fri Aug 26 23:14:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104640, encodeId=8b80104640af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104641, encodeId=72d0104641c2, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=104642, encodeId=4fe2104642bf, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Fri Aug 26 12:32:00 CST 2016, time=2016-08-26, status=1, ipAttribution=)]
    2016-08-26 doctorJiangchao

    继续学习

    0